IM
GRTX

Islet Management’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Islet Management’s Portfolio GRTX Stock Details GRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-58,500
Closed -$418K – 162
2020
Q2 		$418K Buy
+58,500
New +$621K 0.05% 93

Other funds holding GRTX

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Islet Management's GRTX Position: Q3 2020 in Review

Islet Management sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q3 2020, closing a stake of 58,500 shares — an estimated $418K sold.

Islet Management first reported a position in GRTX in Q2 2020 and held it in 1 quarter. The position peaked at $418K in Q2 2020. 44 funds tracked by Wall St. Rank hold GRTX as of Q3 2020.

  • Islet Management reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Islet Management sold 58,500 Galera Therapeutics, Inc. Common Stock shares in Q3 2020, an estimated $418K.
  • Islet Management first reported a position in Galera Therapeutics, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • Islet Management's Galera Therapeutics, Inc. Common Stock position peaked at $418K in Q2 2020.
  • 44 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q3 2020.

Based on Islet Management's 13F filing for Q3 2020, filed 16 Nov 2020.